Free Guides, Frameworks & Templates for Life Sciences Leaders
The biopharma industry faces unprecedented complexity. A $300B patent cliff is reshaping revenue forecasts across the pharma industry. Margin pressure forces hard decisions on pipeline prioritization, manufacturing footprint, and commercial strategy. AI-driven R&D accelerates some timelines while creating new diligence challenges. After a quieter stretch, deal activity is resurging - BCG and Evaluate Pharma both point to increased M&A and licensing momentum through 2026.
Senior executives make high-stakes calls with limited time and incomplete information. Generic playbooks don't work. Neither do theoretical frameworks built by consultants with no operating history. Life sciences leaders need practical tools grounded in real-world experience. Frameworks stress-tested in the field. Guides that reflect how deals, turnarounds, and market entries actually unfold - not how they look in slide decks. That's what this page delivers.
Katogen has compiled resources for biopharma executives, board members, and leadership teams navigating complex strategic decisions. Download what's useful. Use it with your team.
The Biopharma Transformation Playbook
Who it's for: CEOs and leadership teams managing major strategic shifts - whether pivoting therapeutic focus, transitioning platforms, or changing business models entirely.
What it covers: This playbook walks through key transformation phases: diagnosing core problems, building leadership alignment, sequencing operational changes, managing stakeholder communication, and measuring progress. It includes a decision framework for prioritizing transformation levers and a timeline template for phased execution. Biopharma transformation is rarely linear. This guide helps you manage complexity without losing momentum.
Reimbursement Strategy Framework for Biopharma Executives
Who it's for: Commercial leaders, market access teams, and CEOs preparing for product launch or re-launch in complex payer environments.
What it covers: A step-by-step framework for building defensible reimbursement strategies - covering payer segmentation, value dossier development, pricing architecture, contracting strategy, and access optimization. Includes a payer landscape mapping template and checklist for aligning clinical evidence with reimbursement requirements early in development. With formulary pressures and IRA implications continuing to reshape access dynamics in 2026, this framework is more relevant than ever.
M&A Readiness Checklist for Life Sciences Companies
Who it's for: CEOs, CFOs, and boards considering acquisitions, mergers, or being acquired.
What it covers: A structured checklist covering the full M&A readiness spectrum - from data room preparation and IP documentation to management team alignment and integration planning. Includes a pre-deal diagnostic to identify gaps that could delay or derail transactions, plus a post-close integration framework to protect deal value. Based on direct experience across 17 acquisitions, this checklist reflects what actually slows deals down and what acquirers scrutinize most closely.
Drug Delivery Innovation Guide: From Platform to Commercial Strategy
Who it's for: R&D leaders, business development executives, and CEOs evaluating drug delivery platforms or formulation-based differentiation strategies.
What it covers: A practical guide to evaluating and commercializing drug delivery innovations - including platform due diligence criteria, IP strategy considerations, regulatory pathway mapping, and commercial differentiation frameworks. Covers oral, injectable, transdermal, and inhalation delivery formats. Also includes a build-vs-partner decision matrix for companies weighing internal development against licensing or acquisition. Drug delivery remains one of the most underutilized levers in biopharma differentiation. This guide helps you use it strategically.
WORK WITH KATOGEN
If you are navigating a strategic inflection point — a capital raise, an acquisition, a turnaround, a regulatory challenge, or simply a moment where you need an experienced operator in your corner — we would welcome the conversation. Engagements are selective. The first step is a direct conversation to understand your situation and determine where Katogen can add the most value.
